City and state officials, health insurers and advocates are ramping up efforts to reach millions of low-income people at risk of losing their health insurance.
Federal Policy
Posted inPublic Health
Reimagining the Future of Health Research After Sweeping Cuts
The Trump administration’s decimation of the Agency for Healthcare Research and Quality has many academics deeply concerned.
Posted inCost of Care
States Weigh In on Medicaid Fraud
A live conversation with a bipartisan group of state Medicaid leaders on the impact of the Trump administration’s aggressive anti-fraud push.
Posted inPublic Health
Call to Mind: Immigration and the Challenge to Belong
A deep dive on the unique mental health challenges faced by immigrants in America, produced by Call to Mind from American Public Media.
Posted inPublic Health
As Drama at Trump’s FDA Subsides, Doubts and Damage Linger
We talk with STAT News reporter Lizzy Lawrence about the agency’s recent turmoil and its hunt for a new leader.
Posted inCost of Care
Where Did the No Surprises Act Go Wrong? And Can It Be Fixed?
A live conversation with national experts about the unexpected impacts of the consumer protection law, what could be done to change things, and what lessons can be learned about crafting complicated health policy.
Posted inCost of Care
How the No Surprises Act Solved One Problem and Created Another
A conversation co-hosted by Tradeoffs and Penn LDI examines how arbitration rules are inflating payments and overwhelming the system.
Decoding the Moment: Can the No Surprises Act Be Fixed?
Two leading researchers and a former CMS official will discuss why the No Surprises Act has failed to deliver on its cost-cutting promise, what could be done to change things, and whether there are larger lessons for future policy change.
Posted inCost of Care
Doctors Hated the No Surprises Act. Now Some Are Getting Rich Off of It.
Doctors are winning big paydays from insurers under a law intended to protect patients and rein in high prices.
Posted inHealth Law
How a Supreme Court Fight Over Fish Oil Could Raise Your Prescription Drug Costs
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.